NO/cGMP production is important for the endogenous peripheral control of hyperalgesia during inflammation

Nitric Oxide - Biology and Chemistry

Volumn 28, Issue , 2013, Pages 8-13

  Alves, Daniela P ^a   Da Motta, Patrícia G ^a   Romero, Thiago R L ^a   Klein, André ^a   Duarte, Igor D G ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antinociception; cGMP; Inflammatory hyperalgesia; Nitric oxide

Indexed keywords

ARGININE; CARRAGEENAN; CYCLIC GMP; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN E2; ZAPRINAST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; INFLAMMATION; MALE; MECHANICAL STIMULATION; NEUROMODULATION; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PAW EDEMA; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT;

ANIMALS; ARGININE; CARRAGEENAN; CYCLIC GMP; DINOPROSTONE; HYPERALGESIA; INFLAMMATION; MALE; NITRIC OXIDE; PAIN; PAIN MEASUREMENT; PRESSURE; RATS; RATS, WISTAR;

RATTUS;

EID: 84867234825     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2012.09.001     Document Type: Article

References (42)

1. M.J. Millan The induction of pain: an integrative review Prog. Neurobiol. 57 1999 1 164 (Pubitemid 28551764)
2. A.I. Basbaum, and H.L. Fields Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry Annu. Rev. Neurosci. 7 1984 309 338 (Pubitemid 14155301)
3. L.R. Watkins, and D.J. Mayer Multiple endogenous opiate and nonopiate analgesic systems: evidence of their existence and clinical implications Ann. NY Acad. Sci. 467 1986 273 299 (Pubitemid 16029632)
4. A.H. Lichtman, and M.S. Fanselow Cats produce analgesia in rats on the tail flick test: naltrexone sensitivity is determined by the nociceptive test stimulus Brain Res. 12 1990 91 94 (Pubitemid 20375803)
5. H.L. Fields, A.I. Basbaum, Central nervous system mechanisms of pain modulation, in: P.D. Wall, R. Melzack (Ed.), Text Book of Pain, 1999, pp. 243-257.
6. J. Hughes, T.W. Smith, H.W. Kosterlitz, L.A. Fothergill, B.A. Morgan, and H.R. Morris Identification of two related pentapeptides from the brain with potent opiate agonist activity Nature 258 1975 577 579
7. J. Sandkühler The organization and function of endogenous antinociceptive systems Prog. Neurobiol. 50 1996 49 81 (Pubitemid 26362571)
8. S. Fürst Transmitters involved in antinociception in the spinal cord Brain Res. Bull. 48 1999 129 141 (Pubitemid 29177388)
9. H. Machelska, J.K. Schopohl, S.A. Mousa, D. Labuz, M. Schäfer, and C. Stein Different mechanisms of intrinsic pain inhibition in early and late inflammation J. Neuroimmunol. 141 2003 30 39 (Pubitemid 37288994)
10. I.D.G. Duarte, B.B. Lorenzetti, and S.H. Ferreira Peripheral analgesia and activation of the nitric oxide cyclic GMP pathway Eur. J. Pharmacol. 186 1990 289 293 (Pubitemid 20308253)
11. I.D.G. Duarte, I.R. Dos Santos, B.B. Lorenzetti, and S.H. Ferreira Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway Eur. J. Pharmacol. 217 1992 225 227
12. C.R. Tonussi, and S.H. Ferreira Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization Eur. J. Pharmacol. 251 1994 173 179 (Pubitemid 24061092)
13. N.K. Jain, C.S. Patil, A. Singh, and S.K. Kulkarni Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine Pharmacology 67 2003 150 156 (Pubitemid 36184460)
14. G.M.L. Reis, D.F. Pacheco, A.C. Perez, A. Klein, M.A. Ramos, and I.D.G. Duarte Opioid receptor and NO/cGMP pathway as a mechanism of peripheral antinociceptive action of the cannabinoid receptor agonist anandamide Life Sci. 85 2009 351 356
15. 2-adrenoceptor agonist Xylazine induces peripheral antinociceptive effect by activation of the l-arginine/nitric oxide/cyclic GMP pathway in rat Eur. J. Pharmacol. 613 2009 64 67
16. S.H. Ferreira, I.D.G. Duarte, and B.B. Lorenzetti The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release Eur. J. Pharmacol. 201 1991 121 122
17. L.H. Amarante, and I.D.G. Duarte The kappa-opiod agonist bremazocine elicits peripheral antinociception by activation of the l-arginine/nitric oxide/cGMP pathway Eur. J. Pharmacol. 454 2002 19 23 (Pubitemid 35284361)
18. D.F. Pacheco, G.M.L. Reis, J.N. Francischi, M.S. Castro, A.C. Perez, and I.D.G. Duarte Delta-opioid receptor agonist SNC-80 induces peripheral antinociception via delta 1 and delta 2 receptors and activation of the l-arginine/NO/cGMP pathway Life Sci. 78 2005 54 60 (Pubitemid 41527231)
19. D.P. Alves, P.G. Motta, P.P. Lima, C.M. Queiroz-Junior, M.V. Caliari, D.F. Pacheco, C.F. Pacheco, J.N. Francischi, and I.D.G. Duarte Inflammation mobilizes local resources to control hyperalgesia: the role of endogenous opioid peptides Pharmacology. 89 2012 22 28
20. C. Stein, M.J. Millan, T.I. Shippenberg, K. Peter, and A. Herz Peripheral opioid receptors mediating antinociception in inflammation: evidence for involvement of μ, δ and κ receptors J. Pharmacol. Exper. Ther. 248 1989 1269 1275 (Pubitemid 19100783)
21. C. Stein The control of pain in peripheral tissue by opioids N. Engl. J. Med. 332 1995 1685 1690
22. C. Stein, H. Machelska, and M. Schafer Peripheral analgesic and antiinflammatory effects of opioids Z. Rheumatol. 60 2001 416 424 (Pubitemid 34066645)
23. O. Pol The involvement of the nitric oxide in the effects and expression of the opioid receptors during peripheral inflammation Curr. Med. Chem. 14 2009 1945 1955
24. L.O. Randall, and J.J. Selitto A method for measurement of analgesic activity on inflamed tissues Arch. Int. Pharmacodyn. 111 1957 409 419
25. D. Lima, and A. Almeida The medullary dorsal reticular nucleus as a pronociceptive centre of the pain control system Prog. Neurobiol. 66 2002 81 108 (Pubitemid 34256367)
26. M.J. Millan Descending control of pain Prog. Neurobiol. 66 2002 335 474
27. S. Moncada, R.M.J. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology and pharmacology Pharmacol. Rev. 43 1991 109 142
28. C.A. Winter, E.A. Risley, and G.W. Nuss Carrageenan-induced edema in the hind paw of the rat as an assay for anti-inflammatory drugs Proc. Soc. Exp. Biol. 111 1962 544 547
29. R.M.J. Palmer, D.S. Ashton, and S. Moncada Vascular endothelial cells synthesize nitric oxide from l-arginine Nature 333 1988 664 666
30. A. Kawabata, Y. Fukuzumi, Y. Fukushina, and H. Takagi Antinociceptive effect of a l-arginine on the carragenine-induced hyperalgesia of the rat: possible involvement of central opioidergic systems Eur. J. Pharmacol. 218 1992 153 158
31. A. Kawabata, Y. Nishimura, and H. Takagi l-Leucyl-l-arginine, naltrindole and d-arginine block antinociception elicited by l-arginine in mice with carrageenan-induced hyperalgesia Br. J. Pharmacol. 107 1992 1096 1101
32. A. Ialenti, A. Ignaro, S. Moncada, and M. DiRosa Modulation of acute inflammation by endogenous nitric oxide Eur. J. Pharmacol. 211 1992 177 182
33. R.M.J. Palmer, A.G. Ferrige, and S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 526 (Pubitemid 17085822)
34. V. Richard, M. Tschudi, Z. Yang, and T.F. Luscher l-NMMA differentially inhibits endothelium-dependent relaxation to bradykinin and 5-hydroxytryptamine in porcine coronary arteries S. Moncada, E.A. Higgs, Nitric oxide from l-arginine: a bioregulatory system 1990 Elsevier Science Publishers London 439 443 (Pubitemid 20245253)
35. K. Omote, K. Hazama, T. Kawamata, M. Kawamata, Y. Nakayaka, M. Toriyabe, and A. Namiki Peripheral nitric oxide in carrageenan-induced inflammation Brain Res. 912 2001 171 175 (Pubitemid 32800671)
36. D. Koesling, and A. Friebe Soluble guanylylcyclase: structure and regulation Rev. Physiol. Biochem. Pharmacol. 135 1999 41 65
37. F.M. Mullershausen, M. Russwurm, W.J. Thompson, L. Liu, D. Koesling, and A. Friebe Rapid nitric oxide-induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 parelleled by phosphorylation of the enzyme J. Cell. Biol. 155 2003 271 278 (Pubitemid 34289302)
38. J.D. Corbin, and S.H. Francis Pharmacology of phosphodiesterase-5 inhibitors Int. J. Clin. Pract. 56 2002 453 459 (Pubitemid 34855305)
39. E.R. Schwarz, V. Kapur, J. Rodriguez, S. Rastogi, and S. Rosanio The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems Int. J. Impot. Res. 8 2006 35 39
40. M. Ambriz-Tututi, D.A. Velazquez-Zamora, H. Urquiza-Marin, and V. Granados-Soto Analysis of the mechanism underlying the peripheral antinociceptive action of sildenafil in the formalin test Eur. J. Pharmacol. 512 2005 121 127 (Pubitemid 40544345)
41. C.S. Patil, V.P. Singh, and S.K. Kulkarni Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil Inflammopharmacol. 13 2005 467 478 (Pubitemid 41775525)
42. C.I. Araiza-Saldana, G. Reyes-Garcia, D.Y. Bermudez-Ocana, F. Perez-Severiano, and V. Granados-Soto Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats Eur. J. Pharmacol. 527 2005 60 70 (Pubitemid 41745152)